grant
National Institutes of Health
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Source: grants.gov CFDA: Status: forecasted Lifecycle: new
Eligibility
See opportunity for details